Table 3: Distribution of fibroid size reduction after uterine artery embolization by female's bio-clinical data.
Fibroid size reduction |
|||||||||||||
Factors |
< 50% |
50-75% |
> 75% |
P-value |
|||||||||
|
No |
% |
No |
% |
No |
% |
|
||||||
Age in years |
|||||||||||||
< 40 |
11 |
37.9% |
9 |
31.0% |
9 |
31.0% |
0.049* |
||||||
40-49 |
14 |
40.0% |
14 |
40.0% |
7 |
20.0% |
|||||||
50+ |
13 |
61.9% |
4 |
19.0% |
4 |
19.0% |
|||||||
Side |
|||||||||||||
Unilateral |
1 |
100.0% |
0 |
0.0% |
0 |
0.0% |
0.535 |
||||||
Blateral |
37 |
44.0% |
27 |
32.1% |
20 |
23.8% |
|||||||
Mass location |
|||||||||||||
Body |
20 |
47.6% |
14 |
33.3% |
8 |
19.0% |
0.432 |
||||||
Cervix |
2 |
28.6% |
1 |
14.3% |
4 |
57.1% |
|||||||
Fundus |
3 |
30.0% |
5 |
50.0% |
2 |
20.0% |
|||||||
Multiple |
12 |
50.0% |
7 |
29.2% |
5 |
20.8% |
|||||||
No data |
1 |
50.0% |
0 |
0.0% |
1 |
50.0% |
|||||||
Technique |
|||||||||||||
Trans-femoral |
36 |
44.4% |
26 |
32.1% |
19 |
23.5% |
0.956 |
||||||
Trans-radial |
2 |
50.0% |
1 |
25.0% |
1 |
25.0% |
P: Exact probability test